Canseal Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Nashik, Maharashtra, India, established in 2012.
2012 Nashik, Maharashtra, India Struck Off
Last Updated:
Access Report
About Canseal Pharmaceuticals Private Limited

Canseal Pharmaceuticals Private Limited, a struck off private limited company, was established on 17 May 2012 in Nashik, Maharashtra, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24233MH2012PTC231189. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Dinesh Rajabapu Pawar (Director), Pradipkumar Hiralal Kokane (Director), Pankaj Hiralal Kokane (Director). It is based at Plot No 4, Sai Prasad, Chatrapati Nagar Paregaon Road, Yeola, Nashik, Maharashtra, 423401.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233MH2012PTC231189

  • Registration Number

    231189

  • Incorporation Date

    17 May 2012

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 13 Year, 8 Months
Company report

Canseal Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Canseal Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Canseal Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Dinesh Rajabapu Pawar Director 17 May 2012 Current
Pradipkumar Hiralal Kokane Director 17 May 2012 Current
Pankaj Hiralal Kokane Director 17 May 2012 Current
Pushpalata Yashraj Katyare Director 17 May 2012 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Canseal Pharmaceuticals.

Enhance accessibility to Canseal Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Canseal Pharmaceuticals revenue growth over time
Canseal Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Canseal Pharmaceuticals?

Unlock access to Canseal Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Canseal Pharmaceuticals?

Unlock and access historical data on people associated with Canseal Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Canseal Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Canseal Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Canseal Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Dinesh Rajabapu Pawar was appointed as a Director was appointed as a Director on 17 May 2012 & has been associated with this company since 13 years 8 months . was recorded as a recent event.

  • Director Appointment

    The activity Pradipkumar Hiralal Kokane was appointed as a Director was appointed as a Director on 17 May 2012 & has been associated with this company since 13 years 8 months . was completed.

  • Director Appointment

    Progress on Pankaj Hiralal Kokane was appointed as a Director was appointed as a Director on 17 May 2012 & has been associated with this company since 13 years 8 months . was documented.

  • Director Appointment

    Progress on Pushpalata Yashraj Katyare was appointed as a Director was appointed as a Director on 17 May 2012 & has been associated with this company since 13 years 8 months . was documented.

  • Company Incorporation

    The activity Canseal Pharmaceuticals Private Limited was registered on 17 May 2012 with Roc Mumbai & aged 13 years 8 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Canseal Pharmaceuticals Private Limited?

The CIN of Canseal Pharmaceuticals Private Limited is U24233MH2012PTC231189.

Where is Canseal Pharmaceuticals Private Limited headquartered?

Canseal Pharmaceuticals Private Limited is headquartered at Plot No 4, Sai Prasad, Chatrapati Nagar Paregaon Road, Yeola, Nashik, Maharashtra, 423401.

When was Canseal Pharmaceuticals Private Limited incorporated?

Canseal Pharmaceuticals Private Limited was incorporated on 17 May 2012.

Who are the current directors of Canseal Pharmaceuticals Private Limited?

The current directors of Canseal Pharmaceuticals Private Limited are

What is the primary industry of Canseal Pharmaceuticals Private Limited?

The primary industry of Canseal Pharmaceuticals Private Limited is Chemicals.

Is Canseal Pharmaceuticals Private Limited a listed company?

Canseal Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Canseal Pharmaceuticals Private Limited?

The authorized capital of Canseal Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available